Farmers Trust Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79M Sell
27,205
-10,980
-29% -$1.54M 0.6% 61
2025
Q4
$4.69M Buy
38,185
+1,014
+3% +$123K 0.76% 48
2025
Q3
$4.13M Sell
37,171
-11,071
-23% -$1.26M 0.71% 50
2025
Q2
$5.35M Sell
48,242
-492
-1% -$52.4K 1% 38
2025
Q1
$5.46M Sell
48,734
-14,793
-23% -$1.53M 1.03% 38
2024
Q4
$5.87M Sell
63,527
-1,477
-2% -$133K 1.1% 30
2024
Q3
$5.45M Buy
65,004
+2,306
+4% +$176K 1.02% 36
2024
Q2
$4.3M Buy
62,698
+1,993
+3% +$133K 0.87% 41
2024
Q1
$4.45M Buy
60,705
+13,375
+28% +$1.03M 0.9% 43
2023
Q4
$3.83M Buy
+47,330
New +$3.68M 0.8% 46

Other funds holding GILD

Farmers Trust Company's GILD Position: Q1 2026 in Review

Farmers Trust Company reduced its Gilead Sciences (GILD) stake by 29% in Q1 2026, selling an estimated $1.54M and leaving 27,205 shares worth $3.79M. The position accounts for 0.6% of the portfolio, ranked #61.

Farmers Trust Company first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.87M in Q4 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Farmers Trust Company held 27,205 shares of Gilead Sciences worth $3.79M as of Q1 2026.
  • Farmers Trust Company sold 10,980 Gilead Sciences shares in Q1 2026, an estimated $1.54M.
  • Gilead Sciences made up 0.6% of Farmers Trust Company's portfolio in Q1 2026, its #61 holding.
  • Farmers Trust Company first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Farmers Trust Company's Gilead Sciences position peaked at $5.87M in Q4 2024.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Farmers Trust Company's 13F filing for Q1 2026, filed 7 Apr 2026.